ChemoCentryx's stock jumps 80% after receiving FDA approval for vasculitis drug

3 years ago 296

Published: Oct. 8, 2021 astatine 8:24 a.m. ET

Shares of ChemoCentryx Inc. soared 80.3% successful premarket trading connected Friday aft the institution said that it had received support from the Food and Drug Administration for its ANCA-associated vasculitis therapy. The institution said this is the archetypal caller cause to dainty the uncommon autoimmune illness successful a decade. ChemoCentryx's banal slipped 68.3% this year, portion the broader S&P 500 is up 16.1%.

...

Read Entire Article

ChemoCentryx's stock jumps 80% after receiving FDA approval for vasculitis drug

Related

How To Dominate Search Engine Rankings with Guest Posts

The Truth Behind Trading Semiconductor (Chip) Stocks

Is the stock market open today? Here are the trading hours o...

Global stocks advance with U.S. exchanges shut as traders wa...

Trending

Popular

FDA to Add Warning Label to Pfizer, Moderna Vaccines About M...

New York City Adds 629,000 People, Defying Predictions of It...

Astros split doubleheader with Tigers thanks to late home ru...

Blake Shelton and Gwen Stefani are married

Balenciaga Spring